CN1453043A - 处理慢性创伤的微生物纤维素创伤敷料 - Google Patents
处理慢性创伤的微生物纤维素创伤敷料 Download PDFInfo
- Publication number
- CN1453043A CN1453043A CN02151816A CN02151816A CN1453043A CN 1453043 A CN1453043 A CN 1453043A CN 02151816 A CN02151816 A CN 02151816A CN 02151816 A CN02151816 A CN 02151816A CN 1453043 A CN1453043 A CN 1453043A
- Authority
- CN
- China
- Prior art keywords
- cellulose
- dressing
- micro
- deutero
- institute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 138
- 229920002678 cellulose Polymers 0.000 title claims abstract description 124
- 239000001913 cellulose Substances 0.000 title claims abstract description 123
- 208000014674 injury Diseases 0.000 title claims description 67
- 230000006378 damage Effects 0.000 title claims description 37
- 230000002906 microbiologic effect Effects 0.000 title description 8
- 230000009693 chronic damage Effects 0.000 title 1
- 206010052428 Wound Diseases 0.000 claims abstract description 103
- 239000007788 liquid Substances 0.000 claims abstract description 36
- 230000001684 chronic effect Effects 0.000 claims abstract description 32
- 208000000558 Varicose Ulcer Diseases 0.000 claims abstract description 5
- 206010056340 Diabetic ulcer Diseases 0.000 claims abstract description 4
- 239000000758 substrate Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 33
- 230000008733 trauma Effects 0.000 claims description 32
- 238000012360 testing method Methods 0.000 claims description 25
- 244000005700 microbiome Species 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 19
- 239000010409 thin film Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 9
- 230000003068 static effect Effects 0.000 claims description 7
- 241000700199 Cavia porcellus Species 0.000 claims description 6
- 206010070834 Sensitisation Diseases 0.000 claims description 6
- 230000008313 sensitization Effects 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 238000012454 limulus amebocyte lysate test Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 4
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 3
- 241001136169 Komagataeibacter xylinus Species 0.000 claims description 3
- 241000699729 Muridae Species 0.000 claims description 3
- 206010040943 Skin Ulcer Diseases 0.000 claims description 3
- 239000010408 film Substances 0.000 claims description 3
- 231100000019 skin ulcer Toxicity 0.000 claims description 3
- 230000003442 weekly effect Effects 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000010894 electron beam technology Methods 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims 12
- 231100000263 cytotoxicity test Toxicity 0.000 claims 2
- 230000003203 everyday effect Effects 0.000 claims 1
- 238000004078 waterproofing Methods 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 2
- 206010011985 Decubitus ulcer Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 18
- 239000012528 membrane Substances 0.000 description 15
- 238000010521 absorption reaction Methods 0.000 description 14
- 230000029663 wound healing Effects 0.000 description 13
- 239000000017 hydrogel Substances 0.000 description 12
- 239000000416 hydrocolloid Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000002510 pyrogen Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- -1 poly(ethylene oxide) Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 229920013669 Clearsite Polymers 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical group Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011082 depyrogenation Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000019878 epithelium migration Effects 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 208000037997 venous disease Diseases 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (24)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/132171 | 2002-04-26 | ||
US10/132,171 US7390499B2 (en) | 2002-04-26 | 2002-04-26 | Microbial cellulose wound dressing for treating chronic wounds |
US10/173,576 US20030203013A1 (en) | 2002-04-26 | 2002-06-18 | Microbial cellulose wound dressing for treating chronic wounds |
US10/173576 | 2002-06-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1453043A true CN1453043A (zh) | 2003-11-05 |
CN100384485C CN100384485C (zh) | 2008-04-30 |
Family
ID=29272621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021518165A Expired - Fee Related CN100384485C (zh) | 2002-04-26 | 2002-12-02 | 处理慢性创伤的微生物纤维素创伤敷料 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030203013A1 (zh) |
JP (1) | JP4486304B2 (zh) |
CN (1) | CN100384485C (zh) |
AU (1) | AU2003216488A1 (zh) |
CA (1) | CA2484953C (zh) |
WO (1) | WO2003090640A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854453A (zh) * | 2017-12-18 | 2018-03-30 | 济南格莱威医疗科技有限公司 | 一种医用水凝胶护眼敷料 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704523B2 (en) | 2002-04-26 | 2010-04-27 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
US20050019380A1 (en) * | 2002-04-26 | 2005-01-27 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
US7390499B2 (en) * | 2002-04-26 | 2008-06-24 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
EP1667600B1 (en) * | 2003-08-22 | 2014-08-06 | Synthes GmbH | Dura substiture and a process for producing the same |
US8198261B2 (en) * | 2003-08-22 | 2012-06-12 | Xylos Corporation | Thermally modified microbial-derived cellulose for in vivo implantation |
ATE449617T1 (de) * | 2006-02-02 | 2009-12-15 | Euro Celtique Sa | Hydrogel für wundbehandlung |
WO2008026295A1 (fr) * | 2006-09-01 | 2008-03-06 | Toyo Shinyaku Co., Ltd. | Support |
US7832857B2 (en) | 2008-08-18 | 2010-11-16 | Levinson Dennis J | Microbial cellulose contact lens |
US20100158985A1 (en) * | 2008-12-19 | 2010-06-24 | Xylos Corporation | Porous structures of microbial-derived cellulose for in vivo implantation |
WO2011119393A2 (en) * | 2010-03-26 | 2011-09-29 | 3M Innovative Properties Company | Method of sterilization of wound dressings |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3630194A (en) * | 1970-05-22 | 1971-12-28 | Johnson & Johnson | Orthopedic bandage |
US3872862A (en) * | 1973-10-23 | 1975-03-25 | Michael Hume | Dressing and support combination for the treatment of indolent ulcers |
US4942128A (en) * | 1987-03-06 | 1990-07-17 | Board Of Regents, The University Of Texas System | Microbial cellulose modified during synthesis |
US4655758A (en) * | 1982-12-16 | 1987-04-07 | Johnson & Johnson Products, Inc. | Microbial polysaccharide articles and methods of production |
US4588400A (en) * | 1982-12-16 | 1986-05-13 | Johnson & Johnson Products, Inc. | Liquid loaded pad for medical applications |
US4788146A (en) * | 1982-12-16 | 1988-11-29 | Johnson & Johnson Patient Care, Inc. | Liquid loaded pad for medical applications |
US4650674A (en) * | 1984-07-05 | 1987-03-17 | Genentech, Inc. | Synergistic cytotoxic composition |
GB8422070D0 (en) * | 1984-08-31 | 1984-10-03 | Ici Plc | Treated non-woven material |
BR8404937A (pt) * | 1984-10-01 | 1986-05-06 | Bio Fill Ind E Comercio De Pro | Processo para preparacao de pelicula de celulose,pelicula de celulose obtida pelo mesmo,implante de pele artificial,processo de tratamento de lesoes empregando a referida pelicula de celulose e utilizacao |
US4643181A (en) * | 1986-04-04 | 1987-02-17 | Surgikos, Inc. | Antimicrobial dressing or drape material |
US4837079A (en) * | 1988-09-09 | 1989-06-06 | James River Corporation | Antimicrobially active, non-woven web used in a wet wiper |
DE59406509D1 (de) * | 1993-05-26 | 1998-08-27 | Fresenius Ag | Antiinfektivum |
US5955326A (en) * | 1995-08-01 | 1999-09-21 | Rensselaer Polytechnic Institute | Production of microbial cellulose using a rotating disk film bioreactor |
AU720210B2 (en) * | 1996-10-24 | 2000-05-25 | Covidien Ag | Hydrogel wound dressing and the method of making and using the same |
US6008254A (en) * | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
US5846213A (en) * | 1997-06-16 | 1998-12-08 | The University Of Western Ontario | Cellulose membrane and method for manufacture thereof |
US20030190339A1 (en) * | 1997-10-14 | 2003-10-09 | Gregory Skover | Novel skin resurfacing recovery system |
DE19813663A1 (de) * | 1998-03-27 | 1999-10-07 | Beiersdorf Ag | Wundauflagen zur Entfernung von Störfaktoren aus Wundflüssigkeit |
US6143945A (en) * | 1998-04-06 | 2000-11-07 | Augustine Medical, Inc. | Bandage for autolytic wound debridement |
FR2781669B1 (fr) * | 1998-07-31 | 2000-09-15 | Lanatech | Composition cosmetique incluant au moins un polysaccharide provenant de bacteries d'origine hydrothermale |
US6369289B1 (en) * | 2000-07-07 | 2002-04-09 | Tyco Healthcare Group Lp | Method and manufacture of a wound dressing for covering an open wound |
CA2323382C (en) * | 2000-10-17 | 2004-04-13 | Pharma Mag Inc. | Wound dressing |
US7186693B2 (en) * | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
US7704523B2 (en) * | 2002-04-26 | 2010-04-27 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
US20050019380A1 (en) * | 2002-04-26 | 2005-01-27 | Xylos Corporation | Microbial cellulose wound dressing for treating chronic wounds |
US7390499B2 (en) * | 2002-04-26 | 2008-06-24 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
-
2002
- 2002-06-18 US US10/173,576 patent/US20030203013A1/en not_active Abandoned
- 2002-12-02 JP JP2002350445A patent/JP4486304B2/ja not_active Expired - Lifetime
- 2002-12-02 CN CNB021518165A patent/CN100384485C/zh not_active Expired - Fee Related
-
2003
- 2003-03-05 CA CA2484953A patent/CA2484953C/en not_active Expired - Fee Related
- 2003-03-05 AU AU2003216488A patent/AU2003216488A1/en not_active Abandoned
- 2003-03-05 WO PCT/US2003/006416 patent/WO2003090640A2/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854453A (zh) * | 2017-12-18 | 2018-03-30 | 济南格莱威医疗科技有限公司 | 一种医用水凝胶护眼敷料 |
Also Published As
Publication number | Publication date |
---|---|
JP2003321399A (ja) | 2003-11-11 |
WO2003090640A2 (en) | 2003-11-06 |
US20030203013A1 (en) | 2003-10-30 |
AU2003216488A1 (en) | 2003-11-10 |
WO2003090640A3 (en) | 2004-07-29 |
CN100384485C (zh) | 2008-04-30 |
AU2003216488A8 (en) | 2003-11-10 |
JP4486304B2 (ja) | 2010-06-23 |
CA2484953A1 (en) | 2003-11-06 |
CA2484953C (en) | 2011-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7709021B2 (en) | Microbial cellulose wound dressing for treating chronic wounds | |
FI77783B (fi) | Foer medicinska aendamaol avsedd vaetskeimpregnerad saordyna. | |
US4788146A (en) | Liquid loaded pad for medical applications | |
CN102973985B (zh) | 一种具备疏密结构的多孔细菌纤维素皮肤修复材料及其制备方法 | |
Shyna et al. | A nonadherent chitosan-polyvinyl alcohol absorbent wound dressing prepared via controlled freeze-dry technology | |
RU149063U1 (ru) | Повязка для заживления ран с противомикробным действием | |
CN104271166B (zh) | 基于吸收性纤维素的生物材料和植入物 | |
EP1473047A1 (en) | Microbial cellulose wound dressing, containing PHMB, for treating chronic wounds | |
CN103340722B (zh) | 一种吸水性好的卫生巾 | |
JPS60122568A (ja) | 親水性バイオポリマーコポリエレクトロライト | |
CN104623718B (zh) | 壳聚糖凡士林纱布及其制备方法 | |
JPH08260310A (ja) | 微生物多糖製品及びその製造方法 | |
JPS62500630A (ja) | 人工皮膜代用品としてのセルロース皮膜の製造方法 | |
CN101249274A (zh) | 促进伤口愈合的白芨多糖水凝胶的制备及其应用 | |
CN100384485C (zh) | 处理慢性创伤的微生物纤维素创伤敷料 | |
RU2437681C1 (ru) | Раневое покрытие с лечебным действием | |
CN103083112B (zh) | 一种具备疏密结构的细菌纤维素皮肤修复材料及其制备方法 | |
CN110507848B (zh) | 载酶细菌纤维素基复合抗菌水凝胶敷料及其制备方法 | |
CN101700408A (zh) | 一种新型木葡糖酸醋杆菌纤维素水凝胶敷料及其制备方法 | |
KR100372560B1 (ko) | 숯 충진 수화겔 드레싱 및 방사선을 이용한 그의 제조방법 | |
TWI792730B (zh) | 綠梔子素交聯聚乙烯醇/明膠/竹炭奈米顆粒複合材料及其製備方法 | |
CN118542968A (zh) | 一种非均质粘附水凝胶及其制备方法与应用 | |
Susrutha et al. | Types of Wound Dressings and Materials used in Mild to Moderately Exuding Wounds: A Review | |
Burgos | Polymer Medical Dressings Containing Wound Healing Factors. Clinical Studies with Placental Angiogenic and Growth Factors | |
CN114832142A (zh) | 一种壳聚糖复合敷料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1060071 Country of ref document: HK |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LOHMANN & RAUSCHER GMBH & CO K Free format text: FORMER OWNER: CHILOS INC. Effective date: 20070928 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070928 Address after: Austria Yanhe Trelease Applicant after: Lohman and Labors LLC Address before: American New York Applicant before: XYLOS Corp. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Transfer of the right to apply Correct: Austria River tristin. False: Austria. Denise Yanhe Number: 44 Page: 1220 Volume: 23 |
|
ERR | Gazette correction |
Free format text: CORRECT: TRANSFER OF APPLICATION RIGHT; FROM: AUSTRIA TRISTIN RIVER TO: AUSTRIA .TRISTIN RIVER |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1060071 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080430 Termination date: 20211202 |
|
CF01 | Termination of patent right due to non-payment of annual fee |